Company news
Voyageur Pharmaceuticals Ltd news in 2021
Voyageur Pharmaceuticals Ltd's news releases, calls and decks from 2021, newest first.
Voyageur Pharmaceuticals Provides Update on PEA Progress & Takes a Major Step Towards Production Start Up
December 6, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' MOU with Summit Nanotech to Develop Iodine Extraction Technology and Additions to Scientific Advisory Board - Video Available on Investmentpitch.com
November 9, 2021
Voyageur Pharmaceuticals & Summit Nanotech Corporation Sign Memorandum of Understanding for a Technology Development Project
November 8, 2021
Voyageur Pharmaceuticals Ltd., Announces The Completion of a New Scientific Advisory Board With World Class Leading Physicians
October 18, 2021
Voyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading Physicians
September 14, 2021
Voyageur Pharmaceuticals Ltd. Announces Update To PEA and a Related New Opportunity To Market High Purity USP Barium Sulfate
August 19, 2021
Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options and Deferred Share Units
August 12, 2021
Voyageur Pharmaceuticals Announces Board of Director Changes and 2nd quarter Financial Results
July 26, 2021
Voyageur Pharmaceuticals Ltd. Announces Completion of Private Placement
June 14, 2021
Voyageur Pharmaceuticals Ltd. Announces Closing of Second Tranche of Private Placement
May 28, 2021
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast
May 17, 2021
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product Licenses for MultiXThin Radiographic Barium Contrast
May 5, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals and Beneficial Ruling by the D.C. Circuit Court of Appeals Qualifying Voyageurs Products as Devices not Drugs - Video Available on Investmentpitch.com
April 21, 2021
Recent Decision from DC Circuit Court Likely to Result in Less Cost and Faster Approvals for Voyageur Barium Products - Voyageur Hires Team of Experts to Support Product Roll-Out
April 20, 2021
Voyageur Pharmaceuticals Ltd. Announces up to $1,725,000 Private Placement Financing
April 13, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Two New License Approvals from Health Canada for its MultiX Barium Sulfate Powder Covering Oral and Rectal Applications - Video Available on Investmentpitch.com
April 7, 2021
Voyageur Pharmaceuticals Ltd. Announces Two Health Canada Approvals and Issuance of Product Licenses for MultiX Ba; Radiographic Barium Contrast
April 5, 2021
Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options
April 5, 2021
Voyageur Pharmaceuticals Ltd. Signs Manufacturing Agreement With Alberta Veterinarian Laboratories Ltd. for Barium Radiographic Contrast Production
March 23, 2021
Voyageur Pharmaceuticals Ltd. Receives $209,764.05 from Exercise of Warrants and Options
March 10, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Receipt of Approval from Health Canada for Two of the Company's Barium Contrast Products - Video Available on Investmentpitch.com
February 17, 2021
Voyageur Pharmaceuticals Ltd. Announces Second Health Canada Approval and Issuance of Product License for HDXBa; Radiographic Barium Contrast
February 16, 2021
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product License for SmoothX; Radiographic Barium Contrast Suspension
February 12, 2021
Voyageur Pharmaceuticals Ltd. Announces Second and Final Closing of Private Placement and Future Director Retirement
January 18, 2021